# Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

> **NCT00407121** · PHASE3 · WITHDRAWN · sponsor: **Asociación para Evitar la Ceguera en México**

## Conditions studied

- Vogt Koyanagi Harada Disease
- Serpiginous Choroiditis
- Multifocal Choroiditis

## Interventions

- **DRUG:** Bevacizumab
- **PROCEDURE:** Intravitreal Injection of Bevacizumab

## Key facts

- **NCT ID:** NCT00407121
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-12
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Undefined.
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407121, "Intravitreal Bevacizumab for Inflammatory Neovascular Membranes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00407121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*